Work

Phase II Trial of Oblimersen Sodium (G3139), Dexamethasone (Dex) and Thalidomide (Thal) in Relapsed Multiple Myeloma Patients (Pts).

Year: 2004

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v104.11.2400.2400

Authors: Ashrof Z. Badros, Olga Goloubeva, Bashi Ratterree, Sabrina Natt, Aaron Rapoport, Javier Bolaños-Meade, Ben Zhang, Jerry Zeldis, Stanley Frankel, Barry Meisenberg, James Zwiebel, J. Flaws, D. Tomic, Robert Fenton

Institutions: University of Maryland, Baltimore, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Celgene (United States), National Institutes of Health, National Cancer Institute

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2567710541

FWCI: 1.03

Cites:

Cited by: 9

Related to: 10